Literature DB >> 2044234

The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro.

D A Bell1, B Morrison.   

Abstract

Nucleosomes released spontaneously in short-term culture from murine spleen cells have a significant immunoproliferative effect in vitro, including the stimulation of anti-DNA antibody responses. The present studies show that during short-term cultures, tonsil lymphoid cells also undergo spontaneous apoptosis revealed morphologically (electron microscopy) by the appearance of changes in nuclear chromatin, typical of apoptosis and similar to morphologic changes of apoptosis in cultured normal splenic lymphocytes. This process is followed by the release, in the greater than 30-kDa cell free supernatant fraction, of core histones (H2A, H2B, H3, H4) and low molecular weight DNA (approx 160 bp) constituents of nucleosomes. The greater than 30-kDa tonsil lymphocyte cell-free supernatant material containing the constituents of core nucleosomes, as well as the greater than 30-kDa supernatant fractions of tonsil cell lysates harvested at the same time, had a significant immunoproliferative effect on human or murine lymphocytes, increasing both DNA and immunoglobulin synthesis (protein A plaque-forming cells). Thus the release of immunoproliferative nucleosomes form dying human lymphoid cells provides an autocrine lymphocyte stimulatory network which may be important in immunoproliferative disorders and in normal cell turnover. Apoptosis in vivo may also provide a potential source for the circulating nucleosomal DNA identified in plasma in some systemic lupus erythematosus patients as well as contributing to increased polyclonal B lymphocyte stimulation and autoantibody responses in this disorder.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044234     DOI: 10.1016/0090-1229(91)90108-m

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  23 in total

1.  Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

Authors:  M Boes; T Schmidt; K Linkemann; B C Beaudette; A Marshak-Rothstein; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia.

Authors:  P A Courtney; A D Crockard; K Williamson; A E Irvine; R J Kennedy; A L Bell
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

3.  Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas.

Authors:  A Konstantinidou; P Korkolopoulou; E Patsouris; H Mahera; S Hranioti; X Kotsiakis; P Davaris
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

Review 4.  Antinuclear antibody (ANA) testing in patients treated with biological DMARDs: is it useful?

Authors:  Ignacio García-De LaTorre; Ignacio García-Valladares
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

5.  iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.

Authors:  Gabriel J LaBonia; Katelyn R Ludwig; C Bruce Mousseau; Amanda B Hummon
Journal:  Anal Chem       Date:  2017-12-21       Impact factor: 6.986

Review 6.  Apoptotic markers for primary brain tumor prognosis.

Authors:  A E Konstantinidou; P Korkolopoulou; E Patsouris
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

7.  In vitro inhibition of natural-killer-mediated lysis by chromatin fragments.

Authors:  A D Le Lann; G J Fournié; L Boissier; P L Toutain; H Benoist
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

8.  Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.

Authors:  L Leoncini; M T Del Vecchio; T Megha; P Barbini; P Galieni; S Pileri; E Sabattini; F Gherlinzoni; P Tosi; R Kraft
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

9.  Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

10.  Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.

Authors:  L Georgescu; R K Vakkalanka; K B Elkon; M K Crow
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.